Evidence map›Paper›PMID 30475992›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Prevalence and Epidemiological Characteristics of Asymptomatic Malaria Based on Ultrasensitive Diagnostics: A Cross-sectional Study.

Seble Girma, James Cheaveau, Abu Naser Mohon, Dewdunee Marasinghe, Ruth Legese, Nirujah Balasingam, Adugna Abera, Sindew M Feleke, Lemu Golassa, Dylan R Pillai

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Malaria.The New England journal of medicine · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. AsymptomaticJournal of tropical medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Seble GirmaEthiopian Public Health Institute, Addis Ababa University, Ethiopia.
James CheaveauClinical Section of Microbiology, Calgary Laboratory Services, Alberta.
Abu Naser MohonDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Alberta.
Dewdunee MarasingheDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec.
Ruth LegeseDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Alberta.
Nirujah BalasingamDepartment of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Alberta.
Adugna AberaEthiopian Public Health Institute, Addis Ababa University, Ethiopia.
Sindew M FelekeEthiopian Public Health Institute, Addis Ababa University, Ethiopia.
Lemu GolassaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Ethiopia.
Dylan R PillaiClinical Section of Microbiology, Calgary Laboratory Services, Alberta.
University of Calgary · CAAddis Ababa University · ETEthiopian Public Health Institute · ETCalgary Laboratory Services · CAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs the global public-health objectives for malaria evolve from malaria control towards malaria elimination, there is increasing interest in the significance of asymptomatic infections and the optimal diagnostic test to identify them.

methodWe conducted a cross-sectional study of asymptomatic individuals (N = 562) to determine the epidemiological characteristics associated with asymptomatic malaria. Participants were tested by rapid diagnostic tests (CareStart, Standard Diagnostics [SD] Bioline, and Alere ultrasensitive RDT [uRDT]), loop-mediated isothermal amplification (LAMP), and quantitative reverse transcription polymerase chain reaction (qRT-PCR) to determine malaria positivity. Hemoglobin values were recorded, and anemia was defined as a binary variable, according to World Health Organization guidelines.

resultsCompared to reference qRT-PCR, LAMP had the highest sensitivity (92.6%, 95% confidence interval [CI] 86.4-96.5), followed by uRDT Alere Malaria (33.9%, 95% CI 25.5-43.1), CareStart Malaria (14.1%, 95% CI 8.4-21.5), microscopy (5.0%, 95% CI 1.8-10.5), and SD Bioline (5.0%, 95% CI 1.8-10.5). For Plasmodium falciparum specimens only, the sensitivity for uRDT Alere Malaria was 50.0% (95% CI 38.8-61.3) and SD Bioline was 7.3% (95% CI 2.7-15.3). Based on multivariate regression analysis with qRT-PCR as the gold standard, for every 3.2% increase in the prevalence of asymptomatic malaria, hemoglobin decreased by 1 gram per deciliter (prevalence ratio 0.968, 95% CI 0.940-0.997; P = .032). Deletions (4.8%) in hrp2 were noted.

conclusionsWhile uRDT Alere Malaria has superior sensitivity to rapid diagnostic tests and microscopy in detecting asymptomatic malaria, LAMP is superior still. Ultrasensitive diagnostics provide the accurate prevalence estimates of asymptomatic malaria required for elimination.

Indexed as

AdolescentAntigens, ProtozoanAsymptomatic InfectionsChildCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHumansMalariaMaleMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesPlasmodiumPopulation SurveillancePrevalenceProtozoan ProteinsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan Proteinsasymptomaticdiagnosticseliminationmalariaultrasensitive

Identifiers

PMID30475992
OpenAlexW2902520845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.